Sandra O’Toole
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Melanoma and MAPK Pathways 8
- Oncology 40
- Cancer Cells and Metastasis 8
- Cancer-related Molecular Pathways 8
- Co-authors
- Robert L. Sutherland (18 shared papers)Ewan K.A. Millar (28 shared papers)Wendy A. Cooper (25 shared papers)Christina Selinger (29 shared papers)Catriona M. McNeil (18 shared papers)Elizabeth A. Musgrove (12 shared papers)Elena López‐Knowles (8 shared papers)David Lam (1 shared paper)
- Journals
- Pathology (17 papers)Breast Cancer Research (8 papers)Cancer Research (7 papers)Journal of Clinical Pathology (6 papers)Histopathology (6 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Sandra O’Toole
102 papers receiving 4.3k citations
Sandra O’Toole's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 1.1k
- Oncology 1.5k
- Molecular Biology 2.2k
- Pulmonary and Respiratory Medicine 840
- Biochemistry 139
Countries citing papers authored by Sandra O’Toole
This map shows the geographic impact of Sandra O’Toole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra O’Toole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra O’Toole more than expected).
Fields of papers citing papers by Sandra O’Toole
This network shows the impact of papers produced by Sandra O’Toole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra O’Toole. The network helps show where Sandra O’Toole may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra O’Toole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer Hit paper breakdown → | 2015 | 487 |
| 2 | 2009 | 249 | |
| 3 | 2010 | 234 | |
| 4 | 2013 | 228 | |
| 5 | 2011 | 151 | |
| 6 | 2010 | 141 | |
| 7 | 2019 | 140 | |
| 8 | 2010 | 127 | |
| 9 | 2013 | 126 | |
| 10 | 2013 | 122 | |
| 11 | 2017 | 111 | |
| 12 | 2009 | 99 | |
| 13 | 2014 | 98 | |
| 14 | 2013 | 97 | |
| 15 | 2013 | 93 | |
| 16 | 2012 | 89 | |
| 17 | 2014 | 83 | |
| 18 | 2011 | 82 | |
| 19 | 2012 | 77 | |
| 20 | 2016 | 67 |
About Sandra O’Toole
Sandra O’Toole is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 106 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (15 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers), Breast Cancer Treatment Studies (8 papers), Cancer Cells and Metastasis (8 papers), Melanoma and MAPK Pathways (8 papers), Cancer-related Molecular Pathways (8 papers) and Breast Lesions and Carcinomas (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.5k citations), Molecular Biology (2.2k citations), Pulmonary and Respiratory Medicine (840 citations) and Biochemistry (139 citations). Sandra O’Toole has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Robert L. Sutherland, Ewan K.A. Millar, Wendy A. Cooper, Christina Selinger, Catriona M. McNeil, Elizabeth A. Musgrove, Elena López‐Knowles, David Lam, John D. Minna and Alexander Swarbrick. Their work appears in journals such as Pathology, Breast Cancer Research, Cancer Research, Journal of Clinical Pathology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.